I agree that this site is using cookies. You can find further informations here.
X
Morris, Van Karlyle
19  results:
Search for persons X
?
1

Advancements in combining targeted therapy and immunotherap..:

Singh, Manisha ; Morris, Van Karlyle ; Bandey, Irfan N...
Trends in Cancer.  10 (2024)  7 - p. 598-609 , 2024
Link: https://doi.org/10.1016/..
 
?
2

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in ..:

Tabernero, Josep ; Van Cutsem, Eric ; Garralda, Elena...
The Oncologist.  28 (2023)  3 - p. 230-238 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Sustained Disease Control in Immune Checkpoint Blockade Res..:

Simmons, Kristen ; Thomas, Jane V. ; Ludford, Kaysia...
Cancer Research Communications.  3 (2023)  12 - p. 2510-2517 , 2023
Link: https://doi.org/10.1158/..
 
?
4

The Role of Immunotherapy in the Treatment of Anal Cancer a..:

Jácome, Alexandre A. ; Morris, Van Karlyle ; Eng, Cathy
Current Treatment Options in Oncology.  23 (2022)  8 - p. 1073-1085 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Immunotherapy for GI Cancers:

Jácome, Alexandre A. ; Morris, Van Karlyle ; Eng, Cathy
Advances in Oncology.  1 (2021)  - p. 283-295 , 2021
Link: https://doi.org/10.1016/..
 
?
6

T-cell receptor-based therapy: an innovative therapeutic ap..:

Tsimberidou, Apostolia-Maria ; Van Morris, Karlyle ; Vo, Henry Hiep...
Journal of Hematology & Oncology.  14 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
7

Pathological Tumor Response Following Immune Checkpoint Blo..:

Ludford, Kaysia ; Cohen, Romain ; Svrcek, Magali...
JNCI: Journal of the National Cancer Institute.  113 (2020)  2 - p. 208-211 , 2020
Link: https://doi.org/10.1093/..
 
?
8

FBXW7 missense mutation: a novel negative prognostic factor..:

Korphaisarn, Krittiya ; Morris, Van Karlyle ; Overman, Michael J....
Oncotarget.  8 (2017)  24 - p. 39268-39279 , 2017
Link: https://doi.org/10.18632..
 
?
9

Sustained Disease Control in Immune Checkpoint Blockade Res..:

Simmons, Kristen ; Thomas, Jane V ; Ludford, Kaysia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712284/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Feasibility and Safety of Personalized, Multi-Target, Adopt..:

Tsimberidou, Apostolia M ; Guenther, Kerstin ; Andersson, Borje S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330623/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

T-cell receptor-based therapy: an innovative therapeutic ap..:

Tsimberidou, Apostolia-Maria ; Van Morris, Karlyle ; Vo, Henry Hiep...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243554/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Supplemental Figure S1 from Sustained Disease Control in Im..:

Kristen Simmons ; Jane V. Thomas ; Kaysia Ludford...
doi:10.1158/2767-9764.24787414.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
13

FIGURE 2 from Sustained Disease Control in Immune Checkpoin..:

Kristen Simmons ; Jane V. Thomas ; Kaysia Ludford...
doi:10.1158/2767-9764.24787423.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
14

FIGURE 1 from Sustained Disease Control in Immune Checkpoin..:

Kristen Simmons ; Jane V. Thomas ; Kaysia Ludford...
doi:10.1158/2767-9764.24787426.v1.  , 2023
Link: https://doi.org/10.1158/..
 
?
15

FIGURE 4 from Sustained Disease Control in Immune Checkpoin..:

Kristen Simmons ; Jane V. Thomas ; Kaysia Ludford...
doi:10.1158/2767-9764.24787417.v1.  , 2023
Link: https://doi.org/10.1158/..
 
1-15